Shareholder Activism Defense: Why Companies Should Consider a Poison Pill in the Wake of COVID-19

Please join Morgan Lewis corporate partner and shareholder activism defense practice leader Keith E. Gottfried and corporate partner Sean M. Donahue for the webinar, "Shareholder Activism Defense: Why Companies Should Consider a Poison Pill in the Wake of COVID-19.”

In recent weeks, many companies have seen their market capitalizations substantially reduced in the wake of unprecedented volatility in the financial markets driven by the heightened uncertainty surrounding the ongoing coronavirus (COVID-19) pandemic and its impact on the global macroeconomic landscape. Some of these companies may be perceived as extremely attractive targets, even “sitting ducks,” for activist investors, corporate raiders, and/or hostile acquirers. During this 60-minute webinar, we will discuss why companies should consider adopting a “poison pill” (more technically known as a shareholder rights plan), whether a traditional takeover defense poison pill or an NOL poison pill intended to preserve potentially valuable tax assets, or be prepared with a “shelf” poison pill to adopt one on very short notice.